GLP-1 RA tirzepatide may be more cost-effective for patients with obesity and knee osteoarthritis than semaglutide.

As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs ...

Now, a team of researchers from the University of Utah, NYU, and Stanford University has discovered a new option: gait ...

Founded by Dr. Haraprasad, Global Health is a trusted centre for non-surgical treatment of chronic spine, joint, and ...

In this microsimulation model, the two glucagon-like peptide-1 receptor agonists were shown to be cost-effective when added ...

Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...

Netherlands: Wearing a valgus knee brace can meaningfully reduce walking-related pain in patients with medial compartment ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and ...

Minor adjustments to foot angle while walking can improve pain, reduce knee loading, and may slow disease progression in ...

There is a common perception that this crackling, creaking or grinding noise is a sign of a damaged or arthritic knee.

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...